不同处理方式对妊娠期血小板减少症母婴结局分析(2)
总之,对于中重度妊娠期血小板减少症孕妇要给予足够的重视,做到防患于未然,积极避免并发症的发生,保证孕妇和胎儿的安全,顺利分娩。
参考文献
[1]李倩,刘晓松.妊娠期血小板减少症临床与治疗研究进展[J].内蒙古医学杂志,2015,11(2):79-81.
[2]陈哲,梁梅英,张超,等.CD4及CD25调节性T细胞与树突状细胞在妊娠期血小板减少发病机制中的作用[J].中国妇产科临床杂志,2015,15(3):205-208.
[3]何云,张晓辉.妊娠合并血小板减少症的诊断和治疗[J].临床血液学杂志,2015,28(1):7-10.
[4] Greenberg E M,Kaled E S.Thrombocytopenia[J].Crit Care Nyrs Clin North Am,2013,25(4):427-434.
[5] Fyfe-Brown A,Clarke G,Nerenberg K,et al.Management of pregnancy-associated thrombotic thrombocytopenia purpura[J].A J P Rep,2013,3(1):45-50.
[6] Rokx C,Swart R M,Houten A A,et al.Thrombocytopenia during pregnancy[J].Ned Tijdschr Geneeskd,2013,157(33):A6455.
[7]王灵彬,杨颖,李国芸.妊娠合并血小板减少症与母婴预后的分析[J].中国妇幼保健,2007,22(21):2920-2922.
[8] Gernsheimer T B.Thrombocytopenia in pregnancy is this immune thrombocytopenia[J].Hematology Am Soc Hematol Educ Program,2012,20(12):198-202.
[9] Grgic O,Ivanisevic M,Delmis J.Treatment of idiopathic thromboc-ytopenic urpura in pregnancy with pulsed dose of dexamethasone[J].J Obstet Gynaecol,2010,30(8):864., 百拇医药(胡艳梅)
参考文献
[1]李倩,刘晓松.妊娠期血小板减少症临床与治疗研究进展[J].内蒙古医学杂志,2015,11(2):79-81.
[2]陈哲,梁梅英,张超,等.CD4及CD25调节性T细胞与树突状细胞在妊娠期血小板减少发病机制中的作用[J].中国妇产科临床杂志,2015,15(3):205-208.
[3]何云,张晓辉.妊娠合并血小板减少症的诊断和治疗[J].临床血液学杂志,2015,28(1):7-10.
[4] Greenberg E M,Kaled E S.Thrombocytopenia[J].Crit Care Nyrs Clin North Am,2013,25(4):427-434.
[5] Fyfe-Brown A,Clarke G,Nerenberg K,et al.Management of pregnancy-associated thrombotic thrombocytopenia purpura[J].A J P Rep,2013,3(1):45-50.
[6] Rokx C,Swart R M,Houten A A,et al.Thrombocytopenia during pregnancy[J].Ned Tijdschr Geneeskd,2013,157(33):A6455.
[7]王灵彬,杨颖,李国芸.妊娠合并血小板减少症与母婴预后的分析[J].中国妇幼保健,2007,22(21):2920-2922.
[8] Gernsheimer T B.Thrombocytopenia in pregnancy is this immune thrombocytopenia[J].Hematology Am Soc Hematol Educ Program,2012,20(12):198-202.
[9] Grgic O,Ivanisevic M,Delmis J.Treatment of idiopathic thromboc-ytopenic urpura in pregnancy with pulsed dose of dexamethasone[J].J Obstet Gynaecol,2010,30(8):864., 百拇医药(胡艳梅)